FOLLOW US

Bicara Therapeutics $200M IPO

America September 6, 2024

Bicara Therapeutics $200M IPO for Cancer Drug Development

Bicara Therapeutics Inc., a Boston-based clinical-stage biopharmaceutical company, announced on Friday its plans to raise approximately $200 million through an…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter